Metagenomics at the interface of diagnostics and surveillance: a near-term perspective
pdf

Keywords

Metagenomics
infectious diseases
climate-driven shifts in vector ecolog

How to Cite

CADAR , D. (2025) “Metagenomics at the interface of diagnostics and surveillance: a near-term perspective”, One Health & Risk Management , 7(1), pp. 74-76. Available at: https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/972 (Accessed: 9July2026).

Abstract

The global landscape of infectious diseases is undergoing rapid and profound change. Increased human mobility, climate-driven shifts in vector ecology, intensified human-animal-environment interactions, and geopolitical instability have collectively amplified the risk of emerging and re-emerging infectious diseases. At the same time, public health systems are increasingly confronted with pathogens that are unexpected, genetically diverse, or poorly represented in existing diagnostic panels. These developments highlight the growing limitations of exclusively targeted diagnostic approaches and underscore the need for broader, more adaptive tools.

In this context, metagenomic sequencing has emerged as a transformative technology. By enabling unbiased detection and genomic characterization of pathogens directly from clinical, environmental, or animal samples, metagenomics offers capabilities that extend far beyond conventional diagnostics. While historically confined to research and outbreak investigations, metagenomics is now approaching a level of maturity that warrants serious consideration for integration into routine diagnostics and risk-oriented surveillance frameworks.

Metagenomic sequencing is no longer a distant prospect but a rapidly maturing technology with tangible relevance for routine diagnostics and high-risk disease surveillance. While targeted assays will continue to form the backbone of diagnostic testing, metagenomics offers unparalleled breadth and genomic resolution, enabling detection and characterization of pathogens that would otherwise remain undetectable.

The near future of diagnostics will be defined not by the replacement of existing methods, but by their intelligent integration. By combining targeted testing with selective metagenomic analysis, public health systems can enhance preparedness, improve outbreak response, and strengthen biosafety and biosecurity in an increasingly complex global health landscape.

pdf

|Views: 404| |pdf Downloads: 193|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370